Funding news
Antora Energy logo

Antora Energy Raises $150 Million in Series B Funding to Revolutionize Industrial Energy with Zero-Emissions Innovation

Recently funded · $150.0M Series bRenewable Energy

Get the full Antora Energy company profile

Access contacts, investors, buying signals & more

Open in Dashboard

In a significant step towards revolutionizing industrial energy, Antora Energy has successfully raised an impressive $150 million in its latest funding round. Antora is pioneering the future of zero-emissions energy by developing innovative thermal batteries that store renewable energy as heat, which can then be utilized for prolonged periods to meet the demanding energy needs of large industrial operations. By intercepting and harnessing the power of renewables, Antora aims to provide energy that is not only cleaner but also cheaper than traditional fossil fuels, carving a path to eliminate gigatons of emissions while bolstering domestic manufacturing. This funding will be directed towards scaling up operations, furthering research and development, and expanding Antora's workforce with diverse, passionate individuals who prioritize collaboration and innovation. The company is steadfast in its commitment to creating a future where every industrial facility globally can rely on abundant, low-cost, zero-emissions energy. Antora's mission is underpinned by a proactive stance on curbing industrial air pollution and reinforcing America’s position as a leader in clean energy technologies. As the energy landscape evolves, Antora Energy is not just a participant but a transformative force dedicated to building a sustainable future—one thermal battery at a time.

Other recently funded companies

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
EVOKEN GLOBAL logo

EVOKEN GLOBAL

United States

$300.0M
2
Invirsa, Inc logo

Invirsa, Inc

United States

$7.7M
3
BIPO logo

BIPO

Singapore

$50.0M
4
Vertoro B.V. logo

Vertoro B.V.

The Netherlands

$19.7M
5
COUR Pharma logo

COUR Pharma

United States

$50.0M